PlumeSTARS Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $55.3K

  • Investors
  • 2

PlumeSTARS General Information

Description

Developer of antibiotics intended to treat lung infections in patients affected by Cystic Fibrosis. The company discovers novel orphan medicines with the help of technologies applied to different APIs for innovative medicines with a primary interest in inhalation, enabling patients to get antibiotics that can treat them.

Contact Information

Website
www.plumestars.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Viale Parco Area delle Scienze 27/A
  • 43124 Parma
  • Italy
+39 345
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Viale Parco Area delle Scienze 27/A
  • 43124 Parma
  • Italy
+39 345

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PlumeSTARS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 31-Oct-2019 $55.3K Completed Startup
1. Accelerator/Incubator 02-Sep-2013 Completed Startup
To view PlumeSTARS’s complete valuation and funding history, request access »

PlumeSTARS Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

PlumeSTARS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4304552-A1 Novel antiviral compositions and their use in therapy and in the treatment of viral infections Inactive 01-Feb-2021
CA-3191964-A1 Powder composition based on microparticles embedding nanoparticles for the delivery of therapeutic/diagnostic compounds Pending 09-Sep-2020
AU-2021341780-A1 Powder composition based on microparticles embedding nanoparticles for the delivery of therapeutic/diagnostic compounds Pending 09-Sep-2020
EP-4210671-A1 Powder composition based on microparticles embedding nanoparticles for the delivery of therapeutic/diagnostic compounds Active 09-Sep-2020
EP-4210671-B1 Powder composition based on microparticles embedding nanoparticles for the delivery of therapeutic/diagnostic compounds Active 09-Sep-2020 A61K9/1623
To view PlumeSTARS’s complete patent history, request access »

PlumeSTARS Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Union Government
Seedlab Accelerator/Incubator
To view PlumeSTARS’s complete investors history, request access »

Ready to get started?

Request a free trial

PlumeSTARS FAQs

  • When was PlumeSTARS founded?

    PlumeSTARS was founded in 2013.

  • Where is PlumeSTARS headquartered?

    PlumeSTARS is headquartered in Parma, Italy.

  • What industry is PlumeSTARS in?

    PlumeSTARS’s primary industry is Drug Discovery.

  • Is PlumeSTARS a private or public company?

    PlumeSTARS is a Private company.

  • What is PlumeSTARS’s current revenue?

    The current revenue for PlumeSTARS is .

  • Who are PlumeSTARS’s investors?

    European Union and Seedlab have invested in PlumeSTARS.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »